Medical Health & Life Science Research News

Research details developments in the cell-based assays market to hit $19.92 bn by 2022

Medical Market Research

Cell-based assays market report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner greater market shares.

- Advertising -

The major factors driving this market are the growing funding and investments in R&D, the increasing prevalence of chronic disorders, rising drug discovery activity, and the advantages of cell-based assays over alternative technologies. The cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4% during the forecast period from 2017 to 2022.

Download sample study for the 165 pages, report [email protected] www.rnrmarketresearch.com/contacts…mple?rname=173399

 Geographically, the cell-based assays market is dominated by North America, followed by Europe. The Asia-Pacific region is estimated to grow at the fastest rate which can be attributed to the increased investments in the healthcare sector, rising expenditure on healthcare along with increased coverage of health insurance, and a rise in disposable incomes especially in countries like China, Japan, and India.

- Advertising -

 A number of factors, such as growing funding and investments in R&D, the increasing prevalence of chronic disorders, increase in drug discovery activities, and the advantages of cell-based assays over alternative technologies are expected to drive the growth of this market.

The cell-based assays market is classified on the basis of products into consumables, instruments, services and software. The consumables segment is further segmented into reagents, assay kits, micro plates, cell lines, probes & labels and other consumables.

Inquire For Complete Report Copy of Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022 at www.rnrmarketresearch.com/contacts…ying?rname=173399

Cell-Based Assays Market: Competitive Landscape

1 Introduction
2 Market Share Analysis
3 Vendor Dive Overview
   Visionary Leaders
   Innovators
   Dynamic Differentiators
   Emerging Companies
4 Competitive Benchmarking
   Business Strategies Adopted By Major Players in the Global Market (25 Players)
   Analysis of Product Portfolio of Major Players in the Global Market (25 Players) 

Research Coverage:

The report analyses the cell-based assays market by products, applications, end users, and regions. Apart from a comprehensive geographic &product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years.

In addition, the company profiles comprise of product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market.

The Most Useful of global Cell-based assays Market Target Audience for this Report:

  • Cell-based assays manufacturers and vendors
  • Research associations related to drug discovery
  • Healthcare providers (hospitals, laboratories, medical schools, and outpatient clinics)
  • Various research and consulting firms
  • Distributors of cell-based assays
  • Academic and Research Institutes

*Top 25 Companies Analysed for This Study are - Becton, Dickinson and Company. (U.S.), Cell Signaling Technology (U.S.), Danahar Corporation (U.S.), Cisbio Bioassays (France), Merck KGaA (Germany), Ge Healthcare (U.K), Discoverx Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Perkinelmer Inc. (U.S.), Promega Corporation (U.S.), Proqinase GmbH (Germany), Charles River Laboratories International, Inc. (U.S.), Marine Biological Laboratory (U.S.), Biospherix, Ltd. (U.S.), Essen Bioscience (U.S.), Miltenyi Biotec (Switzerland), Bioagilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Lonza (Switzerland), Aurelia Bioscience Ltd. (U.K), Selexis Sa (U.S.), Life Technologies Corporation (U.S.), Cell Biolabs, Inc. (U.S.), Biotek Instruments, Inc. (U.S.), Qgel Sa (Switzerland)

 “Viral Clearance Market” spread across 165 pages, profiling 25+ companies and supported with 86 tables and 48 figures is Direct Order this Report @ www.rnrmarketresearch.com/contacts…hase?rname=173399 

The Key Points of this study are as follows: 

  • To Define, Describe, And Forecast The Cell-Based Assays Market By Product, Application, End User, And Region
  • To Provide Detailed Information Regarding The Major Factors Influencing Growth Of The Market (Drivers, Restraints, And Opportunities)
  • To Analyze Micromarkets With Respect To Individual Growth Trends, Prospects, And Contributions To The Overall Market
  • To Analyze The Opportunities In The Market For Stakeholders And Provide Details Of A Competitive Landscape For Market Leaders
  • To Forecast Revenue Of The Market Segments With Respect To Four Main Regional Segments, Namely, North America, Europe, Asia-Pacific, And The Rest Of The World (Row)
  • To Profile Key Players And Comprehensively Analyze Their Market Shares And Core Competencies In Terms Of Market Developments And Growth Strategies

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.